Skip to main content

Lung Cancer HELPLine 833-797-5800

LUNGevity.org

Navigating NSCLC

Lung Cancer HELPLine 833-797-5800

Visit our other Patient Gateways  

Main navigation

Close Menu
  • About Non-Small Cell Lung Cancer
  • Learn About Clinical Trials
  • Find Your Community
  • News and Events
  • Library

Main navigation

Close Menu
  • NSCLC
    • About Non-Small Cell Lung Cancer
    • Learn About Clinical Trials
    • Find Your Community
    • News and Events
    • Library

NSCLC

Video Library

  • world conference on lung cancer event logo

    Article

    October 02, 2025

    New Insights in Treating Metastatic Lung Cancer from WCLC 2025

    Read time: 3 minutes. For people with advanced or metastatic non-small cell lung cancer (NSCLC), the treatment landscape has changed dramatically in recent years. Researchers are...
    READ MORE about New Insights in Treating Metastatic Lung Cancer from WCLC 2025 ›
  • world conference on lung cancer event logo

    Article

    October 01, 2025

    Biggest News in Early-Stage Lung Cancer Research from WCLC 2025

    Read time: 2 minutes. The annual World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer, is the largest global meeting...
    READ MORE about Biggest News in Early-Stage Lung Cancer Research from WCLC 2025 ›
  • white hair man outdoors calm

    Article

    August 20, 2025

    6 Tips for Managing Scanxiety

    Read time: 4 minutes. Scanxiety is a term used for the anxiety someone feels as a medical exam, like an MRI or CT scan, approaches. It can come with feelings of dread or worry, as...
    READ MORE about 6 Tips for Managing Scanxiety ›
  • Title graphic

    Article

    August 13, 2025

    First Oral Targeted Therapy Approved for Advanced HER2+ NSCLC

    On August 8, 2025, the US Food and Drug Administration (FDA) announced the accelerated approval of zongertinib (Hernexeos®) to treat patients with unresectable or metastatic non...
    READ MORE about First Oral Targeted Therapy Approved for Advanced HER2+ NSCLC ›
  • Title graphic

    Video

    August 11, 2025

    Why Do Some People Who Have Never Smoked Get Lung Cancer?

    As tobacco use has declined in recent years, we have seen a new demographic of lung cancer patients emerge. Lung cancer in individuals who have never smoked (LCINS) is becoming...
    READ MORE about Why Do Some People Who Have Never Smoked Get Lung Cancer? ›
  • Title slide

    Article

    July 03, 2025

    2025 ASCO: Highlights of Lung Cancer Research

    The annual meeting of the American Society of Clinical Oncology (ASCO) once again brought together nearly 50,000 members of the oncology community. From May 30 – June 2...
    READ MORE about 2025 ASCO: Highlights of Lung Cancer Research ›
  • Title slide

    Article

    June 16, 2025

    Surviving LMD: Michelle Never Settled for “No”

    Michelle knew what was wrong. She knew the headaches, regular vomiting, ear popping, and “whooshing” sounds in her head were all signs of leptomeningeal disease (LMD). The issue...
    READ MORE about Surviving LMD: Michelle Never Settled for “No” ›
  • Banner graphic

    Article

    May 20, 2025

    New Treatment Approved for NSCLC with High Level of c-Met Protein

    On May 14, 2025, the US Food and Drug Administration (FDA) announced the approval of telisotuzumab vedotin-tllv (EMRELIS™) to treat patients with locally advanced or metastatic non...
    READ MORE about New Treatment Approved for NSCLC with High Level of c-Met Protein ›
  • HOPE Summit logo

    Video

    May 18, 2025

    Watch HOPE Summit Videos

    HOPE Summit 2025 was filled with messages of hope, meeting new and hugging old friends, and of course the inspirational and informative sessions that help people live well with...
    READ MORE about Watch HOPE Summit Videos ›
  • Titile banner

    Video

    April 16, 2025

    What Are Antibody-Drug Conjugates and How Do They Treat Lung Cancer?

    Historically, approaches to treating lung cancer included surgery, radiation, and chemotherapy. The past decade ushered in a new era of treatments with targeted therapy and...
    READ MORE about What Are Antibody-Drug Conjugates and How Do They Treat Lung Cancer? ›
  • Title graphic

    Video

    April 07, 2025

    Integrative Oncology and Lung Cancer: Adding Complementary Therapy

    What Is Integrative Oncology? Integrative oncology is the use of complementary therapies alongside conventional lung cancer treatments like chemotherapy, targeted therapy, surgery...
    READ MORE about Integrative Oncology and Lung Cancer: Adding Complementary Therapy ›
  • Title slide

    Video

    March 27, 2025

    What Should Patients Know About Lung Cancer Surgery?

    Surgery is a treatment option for early-stage lung cancer that involves removing all or part of a lung to treat a cancerous tumor. It is primarily an option for people with non...
    READ MORE about What Should Patients Know About Lung Cancer Surgery? ›

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page Next ›
  • Last page Last »

You are about to leave the Patient Gateway

You’re one click away from learning about one of our most valued sponsors. Read about how they’re making a difference in patients’ lives.

ProceedCancel

SHARE

The Patient Gateways are a project of LUNGevity Foundation, an organization transforming how people are diagnosed and live with lung cancer. Learn more here.

Privacy policy | Contact us

 

This website is not intended to, and does not, provide medical advice, professional diagnosis, opinion, treatment, or services. Medical information provided on this site is for informational and educational purposes only. After reading content from this website, you are encouraged to review the information carefully with your physician.

 

Copyright © 2025 LUNGevity Foundation. All rights reserved.